DEC 21, 2017 06:11 AM PST

Monocyte Diversity Vital for Personalized Cancer Immunotherapy

WRITTEN BY: Kara Marker

Plucking monocytes out of the human bloodstream is one approach to creating personalized cancer treatments, but this immunotherapy approach hasn’t been as successful as scientists hoped it would be. After learning more about monocytes in a new study from the University of Bonn, scientists and their collaborators learn that these cells are much more diverse than they realized.

Dendritic cells in the corneal epithelium. Credit: Wikimedia user Zhiguo.he

Monocytes are circulating white blood cells of the immune system that are made in the bone marrow before they enter the bloodstream and eventually differentiate into the so-called antigen-presenting cells of the immune system: macrophages, phagocytic immune cells, or dendritic cells.

In the past, scientists have extracted monocytes from the blood of cancer patients to use for immunotherapy, creating monocyte-derived dendritic cells (moDCs) to activate the immune system against tumor cells. However, this therapy approach is rarely effective - why? Can it be made more effective?

The new study, published in the journal Immunity, helped scientists realize that moDCs are not identical descendents of dendritic cells; instead, they are actually quite diverse. To analyze moDCs in their new study, scientists isolated monocytes from human blood samples and transformed the cells into different types of antigen-presenting cells.

"Using state-of-the-art computer-assisted models, we were able to show that moDCs differ from dendritic cells and present a mixture of cells with very diverse properties and functions,” explained lead author Jil Sander.

The variety of moDCs likely explains why cancer immunotherapy based on these cells works in so few patients. However, researchers believe that the moDCs could be altered to fit individual cases of cancer, enhancing the immunotherapy’s success rate.

"MoDCs have an extraordinarily large plasticity, enabling them to tailor their response to pathogens, tumors or endogenous danger signals,” explained second lead author Dr. Susanne V. Schmidt. “This ability is fine-tuned by specific gene regulation.”

Sources: PubMed Health, University of Bonn

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 11, 2018
Immunology
JUN 11, 2018
Post-Trauma Treatment Relieves System-Wide Immune Reaction
The immune response after a traumatic physical injury is essentially the same as a body-wide bacterial infection: inflammatory, systemic, and lethal. From...
JUL 03, 2018
Immunology
JUL 03, 2018
Here's a Virus that Boosts the Immune System
There’s a new therapeutic approach to boosting the weakened immune system that develops naturally with age, but it’s anything but conventional....
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Discovery of New Properties of an Anti-Tuberculosis Drug
  Investigators at the University of Otago found novel properties of a new anti-tuberculosis drug which may inspire more new drugs to treat tuberculos...
JUL 19, 2018
Microbiology
JUL 19, 2018
Mom's Microbiome has a Big Impact on Kid's Autism Risk
For many years, scientists have been trying to learn more about the causes of autism....
JUL 30, 2018
Immunology
JUL 30, 2018
Traumatic Childhood to Addiction, an Immune System Problem
Childhood adversity alters the immune system which contributes to increased risk of addiction as an adult....
AUG 31, 2018
Immunology
AUG 31, 2018
B Cells Control Connective Tissue Disorder Scleroderma
Effector and Regulatory B cells play reciprocal role in pathogenesis of scleroderma....
Loading Comments...